医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

American Physician to Speak in China Addressing Growing Demand for Cosmetic Surgery in Asia

2013年02月04日 PM05:10
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

PORTLAND, Ore.

Dr. Jerry Darm of Aesthetic Medicine in Lake Oswego has been invited by members of the Chinese medical community to speak at a conference of medical professionals in Beijing China regarding the growing demand for cosmetic and plastic surgery procedures throughout Asia and the Far East.

Dr. Darm will be participating in a series of conferences and speaking engagements at several hospitals and medical facilities located throughout China in mid-April. The 14 day trip is part of an on-going exchange program between North American and Chinese medical professionals to collaborate on emerging technology and medical innovations.

Over the past 25 years, social and economic reforms have had tremendous success throughout China. As a result, the demand for high-quality healthcare in China continues to rise with more Chinese citizens interested in Aesthetic and Cosmetic medical procedures. Dr. Darm was asked to participate and share his insights about the growing popularity of plastic and cosmetic surgery.

Dr. Darm will consult with physicians and medical professionals in the cities of Beijing, Shanghai, Suzhou, Nanjing, Wujxi, and Hangzhou.

Dr. Darm opened his private practice in 1995. Initially specializing in weight loss, he expanded to include hair removal and rosacea treatments in 1997. Since that time, new services have been added yearly to promote health, wellness and beauty. Dr. Darm has pioneered his own trademark procedure, LaserLift™ for the treatment of wrinkles, and LipoLift™ for the treatment of unwanted fat and cellulite. He is internationally recognized and sought out by patients from all over the world.

Aesthetic Medicine

4800 Meadows Road, Suite 100, Lake Oswego, OR 97035 1-888-697-9717

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130203005076/en/

CONTACT

Aesthetic Medicine
Melissa Neubert, 503-702-1886
melissa@drdarm.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表